Viewing Study NCT01916135



Ignite Creation Date: 2024-05-06 @ 1:52 AM
Last Modification Date: 2024-10-26 @ 11:10 AM
Study NCT ID: NCT01916135
Status: COMPLETED
Last Update Posted: 2020-04-27
First Post: 2013-07-31

Brief Title: PET Imaging of Cancer Patients Using 18F-SKI-249380 a Radiolabeled Dasatinib-Derivative
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2020-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is the first time that a new experimental drug called 18F-SKI-249380 is being used in people 18F-SKI-249380 is not a therapeutic drug 18F-SKI-249380 is a drug that will be used with PET scanners to see where 18F-SKI-249380 goes in the body after its injected The researchers believe that scans with 18F-SKI-249380 might be able to find tumors in patients

This study is being done to see how long 18F-SKI-249380 stays in the blood when it is given to people in tiny amounts by an injection into a vein in their arm and to see where 18F-SKI-249380 goes in the body If the results of this trial are good then the study doctors plan to use 18F-SKI-249380 in another trial to see if scans with 18F-SKI-249380 are better for finding tumors compared to the standard types of scans that doctors use
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None